3210 Merryfield Row
Abilita Bio was founded in June 2014 and is an innovation-driven biotechnology company focused on enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channels.
Founder and CEO: Mauro Mileni, PhD
COO: Randy Schreckhise
CTO: Rosario Billetta, DSc
Vice President, Innovation: Christopher B. Roth, PhD
Please click here for Ablita Bio job opportunities.
Please click here for Abilita Bio's pipeline.